American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about HC Wainwright Reiterates Buy Rating for PDS Biotechnology (NASDAQ:PDSB)

HC Wainwright Reiterates Buy Rating for PDS Biotechnology (NASDAQ:PDSB)

HC Wainwright reaffirmed their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $21.00 target price... More of this article »
Image about Jefferies Financial Group Cuts Uber Technologies (NYSE:UBER) Price Target to $100.00

Jefferies Financial Group Cuts Uber Technologies (NYSE:UBER) Price Target to $100.00

Uber Technologies (NYSE:UBER – Free Report) had its price target decreased by Jefferies Financial Group from $103.00 to $100.00 in a research report released on Thursday, Benzinga reports. Jefferies Financial Group currently... More of this article »
Image about Olema Pharmaceuticals (NASDAQ:OLMA) PT Raised to $28.00 at HC Wainwright

Olema Pharmaceuticals (NASDAQ:OLMA) PT Raised to $28.00 at HC Wainwright

Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) had its price target upped by HC Wainwright from $25.00 to $28.00 in a research report released on Thursday morning, Benzinga reports. HC Wainwright currently has a buy rating... More of this article »
Image about Jefferies Financial Group Cuts KKR & Co. Inc. (NYSE:KKR) Price Target to $113.00

Jefferies Financial Group Cuts KKR & Co. Inc. (NYSE:KKR) Price Target to $113.00

KKR & Co. Inc. (NYSE:KKR – Free Report) had its price objective lowered by Jefferies Financial Group from $115.00 to $113.00 in a research note issued to investors on Thursday morning, Benzinga reports. The firm currently... More of this article »
Image about The Carlyle Group (NASDAQ:CG) Price Target Cut to $44.00 by Analysts at Jefferies Financial Group

The Carlyle Group (NASDAQ:CG) Price Target Cut to $44.00 by Analysts at Jefferies Financial Group

The Carlyle Group (NASDAQ:CG – Free Report) had its target price decreased by Jefferies Financial Group from $49.00 to $44.00 in a report released on Thursday morning, Benzinga reports. Jefferies Financial Group currently has... More of this article »
Image about Context Therapeutics (NASDAQ:CNTX) PT Raised to $5.00

Context Therapeutics (NASDAQ:CNTX) PT Raised to $5.00

Context Therapeutics (NASDAQ:CNTX – Free Report) had its target price increased by HC Wainwright from $4.00 to $5.00 in a report published on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Separately,... More of this article »
Image about Mizuho Increases Emerson Electric (NYSE:EMR) Price Target to $135.00

Mizuho Increases Emerson Electric (NYSE:EMR) Price Target to $135.00

Emerson Electric (NYSE:EMR – Free Report) had its target price raised by Mizuho from $130.00 to $135.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a buy rating on the industrial... More of this article »
Image about SANUWAVE Health, Inc. (OTCMKTS:SNWV) Sees Significant Increase in Short Interest

SANUWAVE Health, Inc. (OTCMKTS:SNWV) Sees Significant Increase in Short Interest

SANUWAVE Health, Inc. (OTCMKTS:SNWV – Get Free Report) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 121,000 shares, a growth of 18.5% from the April 15th total of... More of this article »
Image about Zacks Research Analysts Decrease Earnings Estimates for Helen of Troy Limited (NASDAQ:HELE)

Zacks Research Analysts Decrease Earnings Estimates for Helen of Troy Limited (NASDAQ:HELE)

Helen of Troy Limited (NASDAQ:HELE – Free Report) – Research analysts at Zacks Research dropped their Q1 2025 earnings per share estimates for Helen of Troy in a research report issued on Wednesday, May 8th. Zacks Research... More of this article »
Image about LQR House Inc. (NASDAQ:LQR) Short Interest Down 25.5% in April

LQR House Inc. (NASDAQ:LQR) Short Interest Down 25.5% in April

LQR House Inc. (NASDAQ:LQR – Get Free Report) was the recipient of a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 88,800 shares, a decline of 25.5% from the April... More of this article »
Image about Short Interest in Louisiana-Pacific Co. (NYSE:LPX) Drops By 25.7%

Short Interest in Louisiana-Pacific Co. (NYSE:LPX) Drops By 25.7%

Louisiana-Pacific Co. (NYSE:LPX – Get Free Report) was the target of a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 935,700 shares, a drop of 25.7% from the... More of this article »
Image about Wells Fargo & Company (NYSE:WFC) Short Interest Up 18.6% in April

Wells Fargo & Company (NYSE:WFC) Short Interest Up 18.6% in April

Wells Fargo & Company (NYSE:WFC) was the target of a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 38,540,000 shares, an increase of 18.6% from the April 15th... More of this article »
Image about Short Interest in Nuveen S&P 500 Dynamic Overwrite Fund (NYSE:SPXX) Rises By 18.5%

Short Interest in Nuveen S&P 500 Dynamic Overwrite Fund (NYSE:SPXX) Rises By 18.5%

Nuveen S&P 500 Dynamic Overwrite Fund (NYSE:SPXX – Get Free Report) was the target of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 32,000 shares, a growth... More of this article »
Image about Northland Capmk Analysts Reduce Earnings Estimates for Evolution Petroleum Co. (NYSEAMERICAN:EPM)

Northland Capmk Analysts Reduce Earnings Estimates for Evolution Petroleum Co. (NYSEAMERICAN:EPM)

Evolution Petroleum Co. (NYSEAMERICAN:EPM – Free Report) – Research analysts at Northland Capmk cut their Q1 2025 earnings per share (EPS) estimates for Evolution Petroleum in a report released on Thursday, May 9th.... More of this article »
Image about HC Wainwright Comments on Century Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:IPSC)

HC Wainwright Comments on Century Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:IPSC)

Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Century Therapeutics in a note issued to investors on... More of this article »